Amryt Pharma plc (LON:AMYT – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 143 ($1.91) and traded as high as GBX 155 ($2.07). Amryt Pharma shares last traded at GBX 143 ($1.91), with a volume of 90,726 shares.
Amryt Pharma Stock Performance
The company has a debt-to-equity ratio of 66.05, a current ratio of 1.80 and a quick ratio of 1.14. The firm has a market cap of £457.11 million and a price-to-earnings ratio of -4.33. The business’s 50-day moving average price is GBX 143 and its two-hundred day moving average price is GBX 143.
Amryt Pharma Company Profile
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Further Reading
- Five stocks we like better than Amryt Pharma
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- About the Markup Calculator
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
